What Ovarian Cancer Drugs Are Available in China? Drug List and Clinical Uses
Ovarian cancer drugs in China mainly include five categories: PARP inhibitors, anti-angiogenic therapies, antibody-drug conjugates…
News
From First- to Third-Generation EGFR-targeted Drugs: How Can Patients Understand Differences in Efficacy and Adverse Effects?
Epidermal growth factor receptor EGFR–targeted drugs represent a cornerstone in the treatment of advanced non–small…
Pharmaceutical Distributor in Hong Kong | Licensed Wholesale & Drug Export Partner
DengYueMed is a licensed Pharmaceutical Distributor in Hong Kong providing wholesale pharmaceuticals, global drug export,…
What Are the Treatment Options for Duchenne Muscular Dystrophy? Current Therapies, Gene Therapy, and Emerging Treatments
What are the treatment options for Duchenne muscular dystrophy? Current treatment options for Duchenne muscular…
China National Essential Medicines List 2026: Key Updates on Innovative Drugs, GLP-1 and Cancer Therapies
On July 9, 2026, China officially released the China National Essential Medicines List 2026, adding…
How to Find the Latest Breast Cancer Drugs: 7 Trusted Steps
How to find the latest breast cancer drugs begins with knowing your breast cancer subtype…
Top 5 Rare Disease Companies: An In-Depth Analysis of Roche, Novartis, Johnson & Johnson, AstraZeneca, and Vertex
The top 5 rare disease companies include Roche, Novartis, Johnson & Johnson, AstraZeneca, and Vertex…
Abbisko’s Pimicotinib for Tenosynovial Giant Cell Tumor (TGCT): China’s First Approved Class-1 CSF-1R Inhibitor
Abbisko’s Pimicotinib for tenosynovial giant cell tumor (TGCT) is an oral CSF-1R inhibitor developed by…
How Do Pharmaceutical Wholesalers Work? A Complete Guide to International Pharmaceutical Procurement
How do pharmaceutical wholesalers work? Pharmaceutical wholesalers source medicines from approved suppliers, manage quality control…
What GLP-1 Drugs Are Available in China?
This guide explains what GLP-1 drugs are available in China, including approved GLP-1 receptor agonists,…